Physician profile
Shamil Shafi
NPI 1770109506
$3,048.59
in general payments reported to CMS, 2019-2025
10 companies · $40.15 in 2025
The $40.15 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $214 · 2022: $578 · 2023: $1,753 · 2024: $464 · 2025: $40.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,101 · Education: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,100.90 |
| Education | $156.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $724.66 | 2023 | Nobelactive |
| Kerr Corporation | $582.40 | 2022-2023 | Maxcem Elite, Optibond All-In-One, Files |
| Ormco Corporation | $541.42 | 2021-2023 | Spark |
| Kulzer, LLC | $376.58 | 2024-2025 | |
| Align Technology, INC. | $347.35 | 2022-2023 | Invisalign |
| Straumann USA LLC | $288.08 | 2021-2025 | |
| Envista Holdings Corporation | $110.29 | 2024 | Spark |
| Henry Schein One, LLC | $45.50 | 2023 | Dentrix |
| 3m Company | $21.03 | 2023 | 3m Espe Paradigm Nano Hybrid Universal Restorative, Scotchbond Universal, 3m Relyx |
| Ortho Organizers, INC. | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shamil Shafi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.